Organon & Co | OGN - 净收入





净收入 更改 日
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Celltrion KRW 8.82B 64.74M 2026-03
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 9.02B 1.51B 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
Glaxosmithkline GBP 1.74B 890.94M 2026-03
Kangmei Pharma CNY -16.56M 12.74M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Merck USD -1.34B 2.9B 2026-06
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Novartis USD 3.16B 747M 2026-03
Organigram Holdings CAD -921K 20.89M 2026-03
Organon & Co USD 108M 38M 2026-06
Ovoca Bio EUR 4.42M 5.19M 2025-12
Pharma Mar EUR -972K 2.5M 2026-06
Qiagen NV USD 103.4M 35.36M 2026-06
Sartorius EUR 65.9M 9.7M 2026-06
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Tilray USD -44.93M 44.61M 2025-09
Zealand Pharma A/S -394M 14.88M 2026-03